CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $34,252
- in 1 filing
Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-07-11 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −46,139 | $43.34 | $2.0M | 138,809 |
| 2018-07-11 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +3,861 | $30.34 | $117K | 142,670 |
| 2018-07-11 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −3,861 | $43.34 | $167K | 138,809 |
| 2018-07-11 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Incentive Stock Option (right to buy) | −3,861 | 0 | ||
| 2018-07-11 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −46,139 | 0 | ||
| 2018-07-11 | MARSH RICHARD M E.V.P., General Counsel | Exercise or conversion | +30,672 | $23.11 | $709K | 154,869 |
| 2018-07-11 | MARSH RICHARD M E.V.P., General Counsel | Sale | −30,672 | $44.00 | $1.3M | 124,197 |
| 2018-07-11 | MARSH RICHARD M E.V.P., General Counsel | Exercise or conversion | +40,000 | $23.11 | $924K | 164,197 |
| 2018-07-11 | MARSH RICHARD M E.V.P., General Counsel | Sale | −40,000 | $42.02 | $1.7M | 124,197 |
| 2018-07-11 | MARSH RICHARD M E.V.P., General Counsel | Gift | −7,623 | 116,574 | ||
| 2018-07-11 | MARSH RICHARD M E.V.P., General Counsel | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −30,672 | 40,000 | ||
| 2018-07-11 | MARSH RICHARD M E.V.P., General Counsel | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −40,000 | 0 | ||
| 2018-06-18 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +57,654 | $30.12 | $1.7M | 196,463 |
| 2018-06-18 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −57,654 | $40.12 | $2.3M | 138,809 |
| 2018-06-18 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +2,346 | $30.12 | $71K | 141,155 |
| 2018-06-18 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −2,346 | $40.12 | $94K | 138,809 |
| 2018-06-18 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Incentive Stock Option (right to buy) | −2,346 | 0 | ||
| 2018-06-18 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −57,654 | 0 | ||
| 2018-06-18 | MARSH RICHARD M E.V.P., General Counsel | Exercise or conversion | +33,000 | $30.34 | $1.0M | 157,197 |
| 2018-06-18 | MARSH RICHARD M E.V.P., General Counsel | Sale | −33,000 | $40.00 | $1.3M | 124,197 |
Page 41 of 60 · 1,194 trades